Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

In this trial, patients receiving oral anticoagulation therapy who required pacemaker or defibrillator surgery were assigned to heparin bridging or continuation of warfarin. Patients receiving warfarin had a markedly lower risk of clinically significant device-pocket hematoma. Each year, an estimate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2013-05, Vol.368 (22), p.2084-2093
Hauptverfasser:	Birnie, David H, Healey, Jeff S, Wells, George A, Verma, Atul, Tang, Anthony S, Krahn, Andrew D, Simpson, Christopher S, Ayala-Paredes, Felix, Coutu, Benoit, Leiria, Tiago L.L, Essebag, Vidal
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticoagulants - administration & dosage Anticoagulants - adverse effects Biological and medical sciences Cerebral infarction Clinical significance Clinical trials Contusions Defibrillators, Implantable Drug therapy Female General aspects Health care Hematoma Hematoma - epidemiology Hematoma - etiology Hematoma - prevention & control Heparin Heparin - administration & dosage Heparin - adverse effects Humans Incidence Ischemia Male Medical sciences Myocardial infarction Pacemaker, Artificial Pacemakers Patients Perioperative Period Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Stroke Surgery Tamponade Thromboembolism Thromboembolism - prevention & control Transient ischemic attack Warfarin Warfarin - administration & dosage Warfarin - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!